Literature DB >> 8034302

A human cDNA coding for the Leydig insulin-like peptide (Ley I-L).

E Burkhardt1, I M Adham, U Hobohm, D Murphy, C Sander, W Engel.   

Abstract

cDNA clones for the human Leydig insulin-like peptide (Ley I-L) have been isolated and characterized. The nucleotide sequence of the 743-bp cDNA includes an incomplete 7-bp 5'-noncoding region, an open reading frame of 393 bp, and a 343-bp 3'-noncoding region. By primer extension analysis, the transcription start site was determined as being 14-bp upstream of the translation start site. The underlying gene is expressed in the testis but not in other organs. From the cDNA sequence, it can be deduced that the Ley I-L protein is synthesized as a 131-amino-acid (aa) preproprotein and that it contains a 24-aa signal peptide. Comparison of the pro Ley I-L protein with members of the insulin-like hormone superfamily predicts that the biologically active hormone, after proteolytic processing of the C peptide, consists of a 31-aa long B chain and a 26-aa long A chain, and that it has a molecular weight of 6.25 kDa.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034302     DOI: 10.1007/bf02272850

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  Amino-acid sequence of human insulin.

Authors:  D S NICOL; L F SMITH
Journal:  Nature       Date:  1960-08-06       Impact factor: 49.962

Review 2.  Growth factors as autocrine and paracrine modulators of male gonadal functions.

Authors:  A R Bellvé; W Zheng
Journal:  J Reprod Fertil       Date:  1989-03

3.  Structure of insulin in 4-zinc insulin.

Authors:  G Bentley; E Dodson; G Dodson; D Hodgkin; D Mercola
Journal:  Nature       Date:  1976-05-13       Impact factor: 49.962

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Genomic sequences of human protamines whose genes, PRM1 and PRM2, are clustered.

Authors:  L Domenjoud; G Nussbaum; I M Adham; G Greeske; W Engel
Journal:  Genomics       Date:  1990-09       Impact factor: 5.736

6.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

7.  Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells.

Authors:  I M Adham; E Burkhardt; M Benahmed; W Engel
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 9.  Hormone families: pancreatic hormones and homologous growth factors.

Authors:  T L Blundell; R E Humbel
Journal:  Nature       Date:  1980-10-30       Impact factor: 49.962

10.  Relaxin gene expression in human ovaries and the predicted structure of a human preprorelaxin by analysis of cDNA clones.

Authors:  P Hudson; M John; R Crawford; J Haralambidis; D Scanlon; J Gorman; G Tregear; J Shine; H Niall
Journal:  EMBO J       Date:  1984-10       Impact factor: 11.598

View more
  5 in total

Review 1.  Paracrine and endocrine roles of insulin-like factor 3.

Authors:  A Ferlin; B Arredi; D Zuccarello; A Garolla; R Selice; C Foresta
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

2.  Contribution of residue B5 to the folding and function of insulin and IGF-I: constraints and fine-tuning in the evolution of a protein family.

Authors:  Youhei Sohma; Qing-xin Hua; Ming Liu; Nelson B Phillips; Shi-Quan Hu; Jonathan Whittaker; Linda J Whittaker; Aubree Ng; Charles T Roberts; Peter Arvan; Stephen B H Kent; Michael A Weiss
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

3.  Structure of the R3/I5 chimeric relaxin peptide, a selective GPCR135 and GPCR142 agonist.

Authors:  Linda M Haugaard-Jönsson; Mohammed Akhter Hossain; Norelle L Daly; Ross A D Bathgate; John D Wade; David J Craik; K Johan Rosengren
Journal:  J Biol Chem       Date:  2008-06-24       Impact factor: 5.157

Review 4.  Expression and Role of INSL3 in the Fetal Testis.

Authors:  Richard Ivell; Linn Salto Mamsen; Claus Yding Andersen; Ravinder Anand-Ivell
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-06       Impact factor: 6.055

5.  Mass Spectrometry Supports That the Structure of Circulating Human Insulin-Like Factor 3 Is a Heterodimer.

Authors:  Jakob Albrethsen; Anders Juul; Anna-Maria Andersson
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-28       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.